medigraphic.com
ISSN 2078-7170 (Electronic)

2023, Number 1

<< Back Next >>

CorSalud 2023; 15 (1)

Supervised cardiovascular rehabilitation and some risk factors in patients with intermittent claudication

Pérez YLM; Ochoa MLA, Tamargo BTO, López RM

Language: Spanish
References: 53
Page: 35-49
PDF size: 439.45 Kb.


ABSTRACT

Introduction: Intermittent claudication is a life-threatening and limb-threatening condition that constitutes a current health problem. It is very common nowadays and is associated with the presence of some risk factors. Supervised physical exer-cises are indicated for the treatment of these patients. Supervised cardiovascular rehabilitation (CVR) can be an effective therapy for these patients.
Objective: To evaluate the effects of supervised cardiovascular rehabilitation on some risk factors in patients with intermittent claudication.
Method: A quasi-experimental, comparative, intervention study was carried out with patients diagnosed with intermittent claudication referred to the department of cardiovascular rehabilitation of the Hospital Clínico Quirúrgico Hermanos Ameijei-ras between January and December 2017. The sample consisted of two groups: group A, that included 47 patients who underwent supervised rehabilitation and group B, that included 59 cases who underwent outpatient physical therapy.
Results: Supervised CVR significantly decreased body mass index (32.8 Kg/m2 vs. 29.6 Kg/m2), values of fibrinogen (349 vs. 294 mg/dL), C-reactive protein (4.8 vs. 2.8 mg/L), glycemia (7.5 vs. 5.6 mmol/L), glycosylated hemoglobin (6.6 vs. 5.6%), total cholesterol (6.3 vs. 4.7 mmol/l) and triglycerides (2.6 vs. 1.4 mmol/l, p<0.001) and increased hemoglobin (12.1 vs. 13.2 g/mL) and HDL cholesterol (0.8 vs. 1.4 mmol/L), p<0.001.
Conclusions: Supervised cardiovascular rehabilitation showed a favorable effect on risk factors in patients with intermittent claudication.


REFERENCES

  1. Aboyans V, Ricco JB, Bartelink MEL, Björck M, Brodmann M, Cohnert T, et al. 2017 ESC Guidelines on the Diagnosis and Treatment of Peripheral Arterial Diseases, in collaboration with the European Society for Vascular Surgery (ESVS): Document covering atherosclerotic disease of extracranial carotid and vertebral, mesenteric, renal, upper and lower extremity arteries. Endorsed by: the European Stroke Organization (ESO) The Task Force for the Diagnosis and Treatment of Peripheral Arterial Diseases of the European Society of Cardiology (ESC) and of the European Society for Vascular Surgery (ESVS). Eur Heart J. 2018;39(9):763-816. DOI: https://doi.org/10.1093/eurheartj/ehx095

  2. Schorr EN, Treat-Jacobson D, Lindquist R. The Relationship Between Peripheral Artery Disease Symptomatology and Ischemia. Nurs Res. 2017;66(5):378-87. DOI: https://doi.org/10.1097/nnr.0000000000000230

  3. Creager MA, Belkin M, Bluth EI, Casey DE, Chaturvedi S, Dake MD, et al. 2012 ACCF/AHA/ACR/SCAI/SIR/STS/SVM/SVN/SVS key data elements and definitions for peripheral atherosclerotic vascular disease: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Clinical Data Standards (Writing Committee to Develop Clinical Data Standards for Peripheral Atherosclerotic Vascular Disease). Circulation. 2012;125(2):395-467. DOI: https://doi.org/10.1161/cir.0b013e31823299a1

  4. Cauley JA, Kassem AM, Lane NE, Thorson S; Osteoporotic Fractures in Men (MrOS) Study Research Group. Prevalent peripheral arterial disease and inflammatory burden. BMC Geriatr [Internet]. 2016 [citado 8 Ene 2022];16(1):213. Disponible en: https://doi.org/10.1186/s12877-016-0389-9

  5. Criqui MH, Aboyans V. Epidemiology of peripheral artery disease. Circ Res. 2015;116(9):1509-26. DOI: https://doi.org/10.1161/circresaha.116.303849

  6. Escobar Alfonso V, Zaldívar Garit M, Rodríguez de la Rosa G, Cabrera Cordovés JC. Factores de riesgo prevalentes en pacientes ingresados por enfermedad cerebrovascular. Rev Cub Med Mil [Internet]. 2014 [citado 8 Ene 2022];43(4):433-40. Disponible en: http://scielo.sld.cu/pdf/mil/v43n4/mil03414.pdf

  7. Martinella Portuondo I, Vega Mengana V, García Massó D, Morlot Ruiz A, Núñez Álvarez D. Caracterización clínica de pacientes portadores de enfermedad vascular periférica complicada. Rev Cub Med Mil [Internet]. 2018 [citado 14 Ene 2022];47(2):117-28. Disponible en: https://revmedmilitar.sld.cu/index.php/mil/article/view/74/181

  8. Rydén L, Grant PJ, Anker SD, Berne C, Cosentino F, Danchin N, et al. Guía de práctica clínica de la ESC sobre diabetes, prediabetes y enfermedad cardiovascular, en colaboración con la European Association for the Study of Diabetes. Rev Esp Cardiol. 2014;67(2):136.e1-136.e56. DOI : https://doi.org/10.1016/j.recesp.2013.10.015

  9. Briet M, Schiffrin EL. Treatment of arterial remodeling in essential hypertension. Curr Hypertens Rep. 2013;15(1):3-9. DOI: https://doi.org/10.1007/s11906-012-0325-0

  10. López-Jiménez F, Pérez-Terzic C, Zeballos PC, Anchique CV, Burdiat G, González K. Consenso de Rehabilitación Cardiovascular y Prevención Secundaria de las Sociedades Interamericana y Sudamericana de Cardiología. Rev Urug Cardiol. 2013;28(2):189-224. Enlace: http://www.scielo.edu.uy/pdf/ruc/v28n2/v28n2a11.pdf

  11. Standards of Medical Care in Diabetes-2017: Summary of Revisions. Diabetes Care. 2017;40(Suppl 1):S4-S5. DOI: https://doi.org/10.2337/dc17-s003

  12. Farooq U, Ray SG. 2014 Guideline for the Management of High Blood Pressure (Eighth Joint National Committee): Take-Home Messages. Med Clin North Am. 2015;99(4):733-8. DOI: https://doi.org/10.1016/j.mcna.2015.02.004

  13. Moreno GM. Definición y clasificación de la obesidad. Rev Med Clin Las Condes. 2012;23(2):124-8. DOI: https://doi.org/10.1016/S0716-8640(12)70288-2

  14. Sharif MR, Kheirkhah D, Madani M, Kashani HH. The Relationship Between Iron Deficiency and Febrile Convulsion: A Case-Control Study. Glob J Health Sci. 2015;8(2):185-9. DOI: https://doi.org/10.5539/gjhs.v8n2p185

  15. Davies MJ, D'Alessio DA, Fradkin J, Kernan WN, Mathieu C, Mingrone G, et al. Management of Hyperglycemia in Type 2 Diabetes, 2018. A Consensus Report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD). Diabetes Care. 2018;41(12):2669-701. DOI: https://doi.org/10.2337/dci18-0033

  16. Cefalu WT, Kaul S, Gerstein HC, Holman RR, Zinman B, Skyler JS, et al. Cardiovascular Outcomes Trials in Type 2 Diabetes: Where Do We Go From Here? Reflections From a Diabetes Care Editors' Expert Forum. Diabetes Care. 2018;41(1):14-31. DOI: https://doi.org/10.2337/dci17-0057

  17. Krishna SM, Moxon JV, Golledge J. A review of the pathophysiology and potential biomarkers for peripheral artery disease. Int J Mol Sci. 2015;16(5):11294-322. DOI: https://doi.org/10.3390/ijms160511294

  18. Bejarano-Lara J, Llamas-Macías FJ, Nuño-Escobar C, Calderón-Llamas MA. Biomarcadores de inflamación en pacientes con enfermedad arterial crónica de extremidades inferiores post-revascularización endovascular. Rev Mex Angiol. 2018;46(2):54-60. Enlace: https://www.medigraphic.com/pdfs/revmexang/an-2018/an182b.pdf

  19. McDermott MM. Exercise training for intermittent claudication. J Vasc Surg. 2017;66(5):1612-20. DOI: https://doi.org/10.1016/j.jvs.2017.05.111

  20. Bendermacher BL, Willigendael EM, Teijink JA, Prins MH. Supervised exercise therapy versus non-supervised exercise therapy for intermittent claudication. Cochrane Database Syst Rev [Internet]. 2006 [citado 14 Ene 2022] Apr 19;(2):CD005263. Disponible en: https://doi.org/10.1002/14651858.cd005263.pub2

  21. Hiramoto JS, Katz R, Ix JH, Wassel C, Rodondi N, Windham BG, et al. Sex differences in the prevalence and clinical outcomes of subclinical peripheral artery disease in the Health, Aging, and Body Composition (Health ABC) study. Vascular. 2014;22(2):142-8. DOI: https://doi.org/10.1177/1708538113476023

  22. Simmons KR, Sinning MA, Pearson JA, Hendrix C. Implementing a home-based exercise prescription for older patients with peripheral arterial disease and intermittent claudication: a quality improvement project. J Vasc Nurs. 2013;31(1):2-8. DOI: https://doi.org/10.1016/j.jvn.2012.06.005

  23. Harwood AE, Smith GE, Cayton T, Broadbent E, Chetter IC. A Systematic Review of the Uptake and Adherence Rates to Supervised Exercise Programs in Patients with Intermittent Claudication. Ann Vasc Surg. 2016;34:280-9. DOI: https://doi.org/10.1016/j.avsg.2016.02.009

  24. Im HW, Baek S, Jee S, Ahn JM, Park MW, Kim WS. Barriers to Outpatient Hospital-Based Cardiac Rehabilitation in Korean Patients With Acute Coronary Syndrome. Ann Rehabil Med. 2018;42(1):154-65. DOI: https://doi.org/10.5535/arm.2018.42.1.154

  25. Resurrección DM, Motrico E, Rigabert A, Rubio-Valera M, Conejo-Cerón S, Pastor L, et al. Barriers for Nonparticipation and Dropout of Women in Cardiac Rehabilitation Programs: A Systematic Review. J Womens Health (Larchmt). 2017;26(8):849-59. DOI: https://doi.org/10.1089/jwh.2016.6249

  26. Guzmán YR, Estrada OL, Tejada PA, Crespo O. Factores relacionados con adherencia a un programa de rehabilitación. RFS Revista Facultad Salud. 2010;2(1):39-50. DOI: https://doi.org/10.25054/rfs.v2i1.28

  27. Mostaza JM, Puras E, Blasco M, Lahoz C, Samaniego ML. Utilización de tratamientos cardiovasculares preventivos y consecución de objetivos terapéuticos en pacientes con enfermedad arterial periférica. Rev Esp Cardiol. 2012;65(8):713-8. DOI: https://doi.org/10.1016/j.recesp.2012.02.020

  28. Martínez Díaz Y, Fernández Quintana LC, Cabrera Zamora JL, Almeida Hernández Loyda. Calidad de vida en pacientes con enfermedad arterial periférica de miembros inferiores en estadios iniciales. Rev Cub Angiol [Internet]. 2018 [citado 14 Ene 2022];19(1):17-27. Disponible en: http://scielo.sld.cu/pdf/ang/v19n1/ang03118.pdf

  29. Delaney CL, Miller MD, Allan RB, Spark JI. The impact of different supervised exercise regimens on endothelial function in patients with intermittent claudication. Vascular. 2015;23(6):561-9. DOI: https://doi.org/10.1177/1708538114558329

  30. Ministerio de Salud Pública. Anuario Estadístico de Salud 2015. La Habana: Dirección de Registros Médicos y Estadísticas de Salud; 2016. Enlace: https://salud.msp.gob.cu/wp-content/Anuario/anuario_2015.pdf

  31. Quirós-Meza G, Salazar-Nassar J, Castillo-Rivas J, Vásquez-Carrillo P, Miranda Ávila P, Fernández-Morales H. Prevalencia y factores de riesgo de enfermedad ateroesclerótica sistémica. Acta Méd Costarric. 2014;56(1):6-11. Enlace: https://www.scielo.sa.cr/pdf/amc/v56n1/art02v56n1.pdf

  32. Mahe G, Pollak AW, Liedl DA, Cohoon KP, Mc Carter C, Rooke TW, et al. Discordant Diagnosis of Lower Extremity Peripheral Artery Disease Using American Heart Association Postexercise Guidelines. Medicine (Baltimore) [Internet]. 2015 [citado 14 Ene 2022];94(31):e1277. Disponible en: https://doi.org/10.1097/md.0000000000001277

  33. Rein P, Beer S, Saely CH, Vonbank A, Drexel H. Prevalence of impaired glucose metabolism in individuals with peripheral arterial disease. Int J Cardiol. 2010;144(2):243-4. DOI: https://doi.org/10.1016/j.ijcard.2009.01.002

  34. Morillas P, Cordero A, Bertomeu V, Gonzalez-Juanatey JR, Quiles J, Guindo J, et al. Prognostic value of low ankle-brachial index in patients with hypertension and acute coronary syndromes. J Hypertens. 2009;27(2):341-7. DOI: https://doi.org/10.1097/hjh.0b013e3283199193

  35. Makin A, Lip GY, Silverman S, Beevers DG. Peripheral vascular disease and hypertension: A forgotten association? J Hum Hypertens. 2001;15(7):447-54. DOI: https://doi.org/10.1038/sj.jhh.1001209

  36. Violi F, Criqui M, Longoni A, Castiglioni C. Relation between risk factors and cardiovascular complications in patients with peripheral vascular disease. Results from the A.D.E.P. study. Atherosclerosis. 1996;120(1-2):25-35. DOI: https://doi.org/10.1016/0021-9150(95)05657-2

  37. Cheng SW, Ting AC, Lau H, Wong J. Epidemiology of atherosclerotic peripheral arterial occlusive disease in Hong Kong. World J Surg. 1999;23(2):202-6. DOI: https://doi.org/10.1007/pl00013161

  38. Singh S, Sethi A, Singh M, Khosla K, Grewal N, Khosla S. Simultaneously measured inter-arm and inter-leg systolic blood pressure differences and cardiovascular risk stratification: a systemic review and meta-analysis. J Am Soc Hypertens. 2015;9(8):640-650.e12. DOI: https://doi.org/10.1016/j.jash.2015.05.013

  39. Gerhard-Herman MD, Gornik HL, Barrett C, Barshes NR, Corriere MA, Drachman DE, et al. 2016 AHA/ACC Guideline on the Management of Patients With Lower Extremity Peripheral Artery Disease: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. J Am Coll Cardiol. 2017;69(11):1465-508. DOI: https://doi.org/10.1016/j.jacc.2016.11.008

  40. Alahdab F, Wang AT, Elraiyah TA, Malgor RD, Rizvi AZ, Lane MA, et al. A systematic review for the screening for peripheral arterial disease in asymptomatic patients. J Vasc Surg. 2015;61(3 Suppl):42S-53S. DOI: https://doi.org/10.1016/j.jvs.2014.12.008

  41. Marcus BH, Albrecht AE, King TK, Parisi AF, Pinto BM, Roberts M, et al. The efficacy of exercise as an aid for smoking cessation in women: A randomized controlled trial. Arch Intern Med. 1999;159(11):1229-34. DOI: https://doi.org/10.1001/archinte.159.11.1229

  42. Reiner Z. Resistance and intolerance to statins. Nutr Metab Cardiovasc Dis. 2014;24(10):1057-66. DOI: https://doi.org/10.1016/j.numecd.2014.05.009

  43. Ix JH, Biggs ML, Kizer JR, Mukamal KJ, Djousse L, Zieman SJ, et al. Association of body mass index with peripheral arterial disease in older adults: the Cardiovascular Health Study. Am J Epidemiol. 2011;174(9):1036-43. DOI: https://doi.org/10.1093/aje/kwr228

  44. Bosevski M, Bosevska G, Stojanovska L. Influence of fibrinogen and C-RP on progression of peripheral arterial disease in type 2 diabetes: a preliminary report. Cardiovasc Diabetol [Internet]. 2013 [citado 14 Ene 2022];12:29. Disponible en: https://doi.org/10.1186/1475-2840-12-29

  45. Stone PA, Yacoub M. Inflammatory biomarkers in peripheral arterial disease. Semin Vasc Surg. 2014;27(3-4):148-51. DOI: https://doi.org/10.1053/j.semvascsurg.2015.01.009

  46. Leon AS, Sanchez O. Meta-analysis of the effects of aerobic exercise training on blood lipids. Circulation. 2001;104(Supl II):II414-II415 [Resumen].

  47. Pérez Yánez LM, Prohías Martínez JA, Rogés Machado R, García Hernández RA. Comportamiento de los factores de riesgo coronario en pacientes rehabilitados en el Hospital Hermanos Ameijeiras. Rev Cuban Cardiol [Internet]. 2012 [citado 15 Ene 2022];18(4):199-203. Disponible en: https://revcardiologia.sld.cu/index.php/revcardiologia/article/view/287

  48. Pérez Yánez LM, García Hernández RA. Factores de riesgo coronarios en pacientes con prótesis aórtica durante rehabilitación cardiaca. Rev Cub Med [Internet]. 2013 [citado 15 Ene 2022];52(2):99-108. Disponible en: http://scielo.sld.cu/pdf/med/v52n2/med03213.pdf

  49. Thompson PD, Crouse SF, Goodpaster B, Kelley D, Moyna N, Pescatello L. The acute versus the chronic response to exercise. Med Sci Sports Exerc. 2001;33(6 Suppl):S438-45. DOI: https://doi.org/10.1097/00005768-200106001-00012

  50. Pérez Yánez LM, Rogés Machado RE, Gutiérrez López A. Rehabilitación cardiovascular en pacientes con claudicación intermitente. CorSalud [Internet]. 2017 [citado 15 Ene 2022];9(2):106-13. Disponible en: https://revcorsalud.sld.cu/index.php/cors/article/view/232/476

  51. Popplewell MA, Bradbury AW. Why do health systems not fund supervised exercise programmes for intermittent claudication? Eur J Vasc Endovasc Surg. 2014;48(6):608-10. DOI: https://doi.org/10.1016/j.ejvs.2014.07.008

  52. Quirós Meza G, Salazar Nassar J, Castillo Rivas J, Miranda Ávila P, Fernández Morales H. Enfermedad arterial periférica de miembros inferiores y factores de riesgo asociados. Experiencia con pacientes ambulatorios de Consulta Externa del Servicio de Neurología del Hospital Dr. Rafael Angel Calderón Guardia. Neuroeje. 2012;25(2):36-43. Enlace: https://neuroeje.com/articulos/35.pdf

  53. Zurita-Cruz JN, Márquez-González H, Miranda-Novales G, Villasís-Keever MÁ. Estudios experimentales: diseños de investigación para la evaluación de intervenciones en la clínica. Rev Alerg Mex. 2018;65(2):178-86. DOI: https://doi.org/10.29262/ram.v65i2.376




2020     |     www.medigraphic.com